Authors: Poeze, M Froon, AHM Ramsay, G Buurman, WA Greve, JWM

Citation: M. Poeze et al., Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: A prospective, multicenter, double-blind, randomized phase II trial, SHOCK, 14(4), 2000, pp. 421-428